These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29368979)

  • 41. Are there glutamate abnormalities in subjects at high risk mental state for psychosis? A review of the evidence.
    Treen D; Batlle S; Mollà L; Forcadell E; Chamorro J; Bulbena A; Perez V
    Schizophr Res; 2016 Mar; 171(1-3):166-75. PubMed ID: 26803691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of intra- and inter-regional interrelations between GABA+, Glx and BOLD during pain perception in the human brain - A combined
    Cleve M; Gussew A; Wagner G; Bär KJ; Reichenbach JR
    Neuroscience; 2017 Dec; 365():125-136. PubMed ID: 28965838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An Exploratory Study of Spectroscopic Glutamatergic Correlates of Cortical Excitability in Depressed Adolescents.
    Lewis CP; Port JD; Frye MA; Vande Voort JL; Ameis SH; Husain MM; Daskalakis ZJ; Croarkin PE
    Front Neural Circuits; 2016; 10():98. PubMed ID: 27965544
    [No Abstract]   [Full Text] [Related]  

  • 44. What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.
    Abbott C; Bustillo J
    Curr Opin Psychiatry; 2006 Mar; 19(2):135-9. PubMed ID: 16612192
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.
    Strzelecki D; Podgórski M; Kałużyńska O; Gawlik-Kotelnicka O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Nutrients; 2015 Oct; 7(10):8767-82. PubMed ID: 26506383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nature of glutamate alterations in substance dependence: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
    Chen T; Tan H; Lei H; Li X; Wu Q; Xu X; Ye Y; Zhong N; Du J; Jiang H; Su H; Zhao M
    Psychiatry Res Neuroimaging; 2021 Sep; 315():111329. PubMed ID: 34271295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional MRS with J-edited lactate in human motor cortex at 4 T.
    Koush Y; de Graaf RA; Jiang L; Rothman DL; Hyder F
    Neuroimage; 2019 Jan; 184():101-108. PubMed ID: 30201463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents.
    Croarkin PE; Nakonezny PA; Wall CA; Murphy LL; Sampson SM; Frye MA; Port JD
    Psychiatry Res Neuroimaging; 2016 Jan; 247():25-33. PubMed ID: 26651598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of brain metabolites change during visual sexual stimulation in healthy women using functional MR spectroscopy.
    Kim TH; Kang HK; Jeong GW
    J Sex Med; 2013 Apr; 10(4):1001-11. PubMed ID: 23347356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Towards a theory of functional magnetic resonance spectroscopy (fMRS): A meta-analysis and discussion of using MRS to measure changes in neurotransmitters in real time.
    Mullins PG
    Scand J Psychol; 2018 Feb; 59(1):91-103. PubMed ID: 29356002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional magnetic resonance spectroscopy of glutamate in schizophrenia and major depressive disorder: anterior cingulate activity during a color-word Stroop task.
    Taylor R; Neufeld RW; Schaefer B; Densmore M; Rajakumar N; Osuch EA; Williamson PC; Théberge J
    NPJ Schizophr; 2015; 1():15028. PubMed ID: 27336037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigating the metabolic alterations in a depressive-like rat model of chronic forced swim stress: An in vivo proton magnetic resonance spectroscopy study at 7T.
    Yoo CH; Lim SI; Song KH; Woo DC; Choe BY
    Neurochem Int; 2018 Jun; 116():22-29. PubMed ID: 29530754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Event-related functional magnetic resonance spectroscopy.
    Koolschijn RS; Clarke WT; Ip IB; Emir UE; Barron HC
    Neuroimage; 2023 Aug; 276():120194. PubMed ID: 37244321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.
    Stone JM
    Curr Pharm Des; 2009; 15(22):2594-602. PubMed ID: 19689330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proton magnetic resonance spectroscopy of the human brain in schizophrenia.
    Deicken RF; Johnson C; Pegues M
    Rev Neurosci; 2000; 11(2-3):147-58. PubMed ID: 10718151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imaging Brain Glx Dynamics in Response to Pressure Pain Stimulation: A
    Jelen LA; Lythgoe DJ; Jackson JB; Howard MA; Stone JM; Egerton A
    Front Psychiatry; 2021; 12():681419. PubMed ID: 34393848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    Jahng GH; Oh J; Lee DW; Kim HG; Rhee HY; Shin W; Paik JW; Lee KM; Park S; Choe BY; Ryu CW
    J Alzheimers Dis; 2016 Mar; 52(1):145-59. PubMed ID: 27060946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current Practice and New Developments in the Use of In Vivo Magnetic Resonance Spectroscopy for the Assessment of Key Metabolites Implicated in the Pathophysiology of Schizophrenia.
    Dwyer GE; Hugdahl K; Specht K; Grüner R
    Curr Top Med Chem; 2018; 18(21):1908-1924. PubMed ID: 30499397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proton magnetic resonance spectroscopic imaging of gray and white matter in bipolar-I and schizophrenia.
    Bustillo JR; Jones T; Qualls C; Chavez L; Lin D; Lenroot RK; Gasparovic C
    J Affect Disord; 2019 Mar; 246():745-753. PubMed ID: 30623820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
    Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
    Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.